Serveur d'exploration sur l'automédication dans le monde francophone

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey.

Identifieur interne : 000273 ( Main/Exploration ); précédent : 000272; suivant : 000274

Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey.

Auteurs : Jerry Tan [Canada] ; Martin Steinhoff [Qatar] ; Anthony Bewley [Royaume-Uni] ; Uwe Gieler [Allemagne] ; Vincent Rives

Source :

RBID : pubmed:31120382

Descripteurs français

English descriptors

Abstract

Objective: To characterize rosacea features suitable for identification of high-burden (HB) subjects in clinical practice.Design: Global online survey with subjects recruited using an online panel from the United States, Canada, Italy, United Kingdom, Germany and France. Subjects self-reported a physician's diagnosis of rosacea.Measurements: HB subjects were defined as those with ≥3/4 domains (quality of life, lifestyle adaptation, time trade-off, willingness to pay) greater than the median. Group characteristics were analyzed and multivariate-logistic modeling used to investigate factors most associated with HB.Results: 710 subjects completed the survey, including 158 HB subjects. HB was observed in all self-declared rosacea severities. HB subjects were more likely to spend more time daily on skin care and experienced approximately double the impact of health problems on work productivity in the past 7 days (p < .01). In the past 12 months, HB subjects were more likely to have at least one visit to the emergency room (41.8% vs 11.2%; p < .01). In the multivariate risk analysis, factors most associated with HB included rosacea severity, impact of health problems on regular daily activities and age at first symptoms.Conclusion: Rosacea has a distinct subset of HB subjects who can be successfully characterized.

DOI: 10.1080/09546634.2019.1623368
PubMed: 31120382


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey.</title>
<author>
<name sortKey="Tan, Jerry" sort="Tan, Jerry" uniqKey="Tan J" first="Jerry" last="Tan">Jerry Tan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Western University, Windsor Clinical Research Inc, Windsor, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, Western University, Windsor Clinical Research Inc, Windsor, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Steinhoff, Martin" sort="Steinhoff, Martin" uniqKey="Steinhoff M" first="Martin" last="Steinhoff">Martin Steinhoff</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Dermatology, Translational Research Institute, Hamad Medical Corporation, Weill Cornell University Qatar, Qatar University, Doha, Qatar.</nlm:affiliation>
<country xml:lang="fr">Qatar</country>
<wicri:regionArea>Department of Dermatology, Translational Research Institute, Hamad Medical Corporation, Weill Cornell University Qatar, Qatar University, Doha</wicri:regionArea>
<wicri:noRegion>Doha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bewley, Anthony" sort="Bewley, Anthony" uniqKey="Bewley A" first="Anthony" last="Bewley">Anthony Bewley</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Dermatology, Royal London Hospital, Barts Health NHS Trust and Queen Mary College of Medicine, University of London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Dermatology, Royal London Hospital, Barts Health NHS Trust and Queen Mary College of Medicine, University of London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">Université de Londres</orgName>
</affiliation>
</author>
<author>
<name sortKey="Gieler, Uwe" sort="Gieler, Uwe" uniqKey="Gieler U" first="Uwe" last="Gieler">Uwe Gieler</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University of Giessen, Giessen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University of Giessen, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rives, Vincent" sort="Rives, Vincent" uniqKey="Rives V" first="Vincent" last="Rives">Vincent Rives</name>
<affiliation>
<nlm:affiliation>Galderma, La Defense, France (employee at time of survey).</nlm:affiliation>
<wicri:noCountry code="subField">France (employee at time of survey)</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:31120382</idno>
<idno type="pmid">31120382</idno>
<idno type="doi">10.1080/09546634.2019.1623368</idno>
<idno type="wicri:Area/Main/Corpus">000476</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000476</idno>
<idno type="wicri:Area/Main/Curation">000476</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000476</idno>
<idno type="wicri:Area/Main/Exploration">000476</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey.</title>
<author>
<name sortKey="Tan, Jerry" sort="Tan, Jerry" uniqKey="Tan J" first="Jerry" last="Tan">Jerry Tan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Western University, Windsor Clinical Research Inc, Windsor, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, Western University, Windsor Clinical Research Inc, Windsor, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Steinhoff, Martin" sort="Steinhoff, Martin" uniqKey="Steinhoff M" first="Martin" last="Steinhoff">Martin Steinhoff</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Dermatology, Translational Research Institute, Hamad Medical Corporation, Weill Cornell University Qatar, Qatar University, Doha, Qatar.</nlm:affiliation>
<country xml:lang="fr">Qatar</country>
<wicri:regionArea>Department of Dermatology, Translational Research Institute, Hamad Medical Corporation, Weill Cornell University Qatar, Qatar University, Doha</wicri:regionArea>
<wicri:noRegion>Doha</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bewley, Anthony" sort="Bewley, Anthony" uniqKey="Bewley A" first="Anthony" last="Bewley">Anthony Bewley</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Dermatology, Royal London Hospital, Barts Health NHS Trust and Queen Mary College of Medicine, University of London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Dermatology, Royal London Hospital, Barts Health NHS Trust and Queen Mary College of Medicine, University of London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">Université de Londres</orgName>
</affiliation>
</author>
<author>
<name sortKey="Gieler, Uwe" sort="Gieler, Uwe" uniqKey="Gieler U" first="Uwe" last="Gieler">Uwe Gieler</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University of Giessen, Giessen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University of Giessen, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rives, Vincent" sort="Rives, Vincent" uniqKey="Rives V" first="Vincent" last="Rives">Vincent Rives</name>
<affiliation>
<nlm:affiliation>Galderma, La Defense, France (employee at time of survey).</nlm:affiliation>
<wicri:noCountry code="subField">France (employee at time of survey)</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of dermatological treatment</title>
<idno type="eISSN">1471-1753</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Internet (MeSH)</term>
<term>Life Style (MeSH)</term>
<term>Logistic Models (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Patient Acceptance of Health Care (MeSH)</term>
<term>Quality of Life (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Rosacea (economics)</term>
<term>Rosacea (pathology)</term>
<term>Rosacea (psychology)</term>
<term>Self Report (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acceptation des soins par les patients (MeSH)</term>
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Autorapport (MeSH)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Internet (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mode de vie (MeSH)</term>
<term>Modèles logistiques (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Qualité de vie (MeSH)</term>
<term>Rosacée (anatomopathologie)</term>
<term>Rosacée (psychologie)</term>
<term>Rosacée (économie)</term>
<term>Sujet âgé (MeSH)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Rosacée</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en">
<term>Rosacea</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Rosacea</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Rosacée</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Rosacea</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr">
<term>Rosacée</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Internet</term>
<term>Life Style</term>
<term>Logistic Models</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Patient Acceptance of Health Care</term>
<term>Quality of Life</term>
<term>Risk Factors</term>
<term>Self Report</term>
<term>Severity of Illness Index</term>
<term>Surveys and Questionnaires</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Acceptation des soins par les patients</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Autorapport</term>
<term>Enquêtes et questionnaires</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Internet</term>
<term>Jeune adulte</term>
<term>Mode de vie</term>
<term>Modèles logistiques</term>
<term>Mâle</term>
<term>Qualité de vie</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<b>Objective:</b>
To characterize rosacea features suitable for identification of high-burden (HB) subjects in clinical practice.
<b>Design:</b>
Global online survey with subjects recruited using an online panel from the United States, Canada, Italy, United Kingdom, Germany and France. Subjects self-reported a physician's diagnosis of rosacea.
<b>Measurements:</b>
HB subjects were defined as those with ≥3/4 domains (quality of life, lifestyle adaptation, time trade-off, willingness to pay) greater than the median. Group characteristics were analyzed and multivariate-logistic modeling used to investigate factors most associated with HB.
<b>Results:</b>
710 subjects completed the survey, including 158 HB subjects. HB was observed in all self-declared rosacea severities. HB subjects were more likely to spend more time daily on skin care and experienced approximately double the impact of health problems on work productivity in the past 7 days (
<i>p</i>
 < .01). In the past 12 months, HB subjects were more likely to have at least one visit to the emergency room (41.8% vs 11.2%;
<i>p</i>
 < .01). In the multivariate risk analysis, factors most associated with HB included rosacea severity, impact of health problems on regular daily activities and age at first symptoms.
<b>Conclusion:</b>
Rosacea has a distinct subset of HB subjects who can be successfully characterized.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">31120382</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-1753</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>31</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2020</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of dermatological treatment</Title>
<ISOAbbreviation>J Dermatolog Treat</ISOAbbreviation>
</Journal>
<ArticleTitle>Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey.</ArticleTitle>
<Pagination>
<MedlinePgn>168-174</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/09546634.2019.1623368</ELocationID>
<Abstract>
<AbstractText>
<b>Objective:</b>
To characterize rosacea features suitable for identification of high-burden (HB) subjects in clinical practice.
<b>Design:</b>
Global online survey with subjects recruited using an online panel from the United States, Canada, Italy, United Kingdom, Germany and France. Subjects self-reported a physician's diagnosis of rosacea.
<b>Measurements:</b>
HB subjects were defined as those with ≥3/4 domains (quality of life, lifestyle adaptation, time trade-off, willingness to pay) greater than the median. Group characteristics were analyzed and multivariate-logistic modeling used to investigate factors most associated with HB.
<b>Results:</b>
710 subjects completed the survey, including 158 HB subjects. HB was observed in all self-declared rosacea severities. HB subjects were more likely to spend more time daily on skin care and experienced approximately double the impact of health problems on work productivity in the past 7 days (
<i>p</i>
 < .01). In the past 12 months, HB subjects were more likely to have at least one visit to the emergency room (41.8% vs 11.2%;
<i>p</i>
 < .01). In the multivariate risk analysis, factors most associated with HB included rosacea severity, impact of health problems on regular daily activities and age at first symptoms.
<b>Conclusion:</b>
Rosacea has a distinct subset of HB subjects who can be successfully characterized.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Jerry</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Western University, Windsor Clinical Research Inc, Windsor, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Steinhoff</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, Translational Research Institute, Hamad Medical Corporation, Weill Cornell University Qatar, Qatar University, Doha, Qatar.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bewley</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology, Royal London Hospital, Barts Health NHS Trust and Queen Mary College of Medicine, University of London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gieler</LastName>
<ForeName>Uwe</ForeName>
<Initials>U</Initials>
<AffiliationInfo>
<Affiliation>Department of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University of Giessen, Giessen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rives</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Galderma, La Defense, France (employee at time of survey).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>06</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Dermatolog Treat</MedlineTA>
<NlmUniqueID>8918133</NlmUniqueID>
<ISSNLinking>0954-6634</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="ErratumIn">
<RefSource>J Dermatolog Treat. 2019 Sep 10;:1</RefSource>
<PMID Version="1">31500476</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012393" MajorTopicYN="N">Rosacea</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Characterize</Keyword>
<Keyword MajorTopicYN="N">high burden</Keyword>
<Keyword MajorTopicYN="N">quality of life</Keyword>
<Keyword MajorTopicYN="N">rosacea</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>5</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>5</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31120382</ArticleId>
<ArticleId IdType="doi">10.1080/09546634.2019.1623368</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Canada</li>
<li>Qatar</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
<orgName>
<li>Université de Londres</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Rives, Vincent" sort="Rives, Vincent" uniqKey="Rives V" first="Vincent" last="Rives">Vincent Rives</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Tan, Jerry" sort="Tan, Jerry" uniqKey="Tan J" first="Jerry" last="Tan">Jerry Tan</name>
</noRegion>
</country>
<country name="Qatar">
<noRegion>
<name sortKey="Steinhoff, Martin" sort="Steinhoff, Martin" uniqKey="Steinhoff M" first="Martin" last="Steinhoff">Martin Steinhoff</name>
</noRegion>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Bewley, Anthony" sort="Bewley, Anthony" uniqKey="Bewley A" first="Anthony" last="Bewley">Anthony Bewley</name>
</region>
</country>
<country name="Allemagne">
<noRegion>
<name sortKey="Gieler, Uwe" sort="Gieler, Uwe" uniqKey="Gieler U" first="Uwe" last="Gieler">Uwe Gieler</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000273 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000273 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    AutomedicationFrancoV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31120382
   |texte=   Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31120382" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AutomedicationFrancoV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Mon Mar 15 15:24:36 2021. Site generation: Mon Mar 15 15:32:03 2021